Join Dr. James Neuenschwander, M.D., FACEP, FASAM on Wednesday, September 8, 12:15 - 12:45 pm as he presents New Practitioner Lunch + Learn: "ANDEXXA: The First and Only FDA-approved Agent for Reversal of FXa Inhibitor Activity in Patients With Life-threatening or Uncontrolled Bleeding".
Be sure to hop on at noon for networking!
After registering, you will receive a confirmation email containing information about joining the meeting.
NOTE: There is no continuing pharmacy education (CPE) credit assigned to this event.
Interested in presenting a Lunch + Learn, NPX wants YOU! Whether you're a student or new practitioner, NPX is looking for speakers to present on a variety of topics.